Harpoon Therapeutics, Inc.
HARPDelisted Mar 11, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001708493
Harpoon Therapeutics, Inc. was delisted on Mar 11, 2024; its insiders filed their last Form 4 on Mar 11, 2024; 41 institutions reported holding it in 13F filings for Q4 2023, worth $175.5M in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in Harpoon Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
HARP is no longer listed, and 13F filings after Q4 2023 list far fewer holders. See Q4 2023
- Institutional holders
- 0
- −41 vs. Q4 2023
- Shares held
- 0
- −15.8M (−100.0%) vs. Q4 2023
- Total value
- $0
- −$175.5M (−100.0%) vs. Q4 2023
- New holders
- 0
- 0 more added
- Sold out
- 41
- 0 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HARP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 41 | $175.5M |
| Q3 2023 | 32 | $7.53M |
| Q2 2023 | 44 | $12.0M |
| Q1 2023 | 46 | $12.9M |
| Q4 2022 | 49 | $13.7M |
| Q3 2022 | 52 | $21.0M |
| Q2 2022 | 63 | $43.4M |
| Q1 2022 | 79 | $128.2M |
| Q4 2021 | 84 | $196.3M |
| Q3 2021 | 93 | $203.9M |
| Q2 2021 | 85 | $357.3M |
| Q1 2021 | 88 | $562.3M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Harpoon Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −2,349,060−100.0% | Sold out |
| New Leaf Venture Partners, L.L.C. | 0 | $0 | 0.00% | −1,859,168−100.0% | Sold out |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −1,500,000−100.0% | Sold out |
| Commodore Capital LP | 0 | $0 | 0.00% | −1,500,000−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −1,492,368−100.0% | Sold out |
| Artal Group S.A. | 0 | $0 | 0.00% | −1,304,127−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −880,017−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −820,638−100.0% | Sold out |
| Blackstone Group Inc. | 0 | $0 | 0.00% | −815,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −685,000−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −428,400−100.0% | Sold out |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −319,670−100.0% | Sold out |
| MPM Asset Management LLC | 0 | $0 | 0.00% | −313,136−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Sio Capital Management, LLC | 0 | $0 | 0.00% | −297,936−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −249,834−100.0% | Sold out |
| Lion Point Capital, LP | 0 | $0 | 0.00% | −228,900−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −149,262−100.0% | Sold out |
| Kennedy Capital Management, Inc. | 0 | $0 | 0.00% | −52,160−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −48,948−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −39,222−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −27,042−100.0% | Sold out |
| Standard Life Aberdeen plc | 0 | $0 | 0.00% | −25,991−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −25,465−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −24,080−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −12,756−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −11,401−100.0% | Sold out |
| Caxton Corp | 0 | $0 | 0.00% | −13,176−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −10,476−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −7,407−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −5,943−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2,608−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −252−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −181−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −134−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −107−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −105−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −8−100.0% | Sold out |